5IMPERIALE TF,O'CONNOR JB,MCCULOUGH AJ.Corticosteroids are effective in patients with severe alcoholic hepatitis.Am J Gastroenterol,1999,94:3066-3068. 被引量：1
7MEDINA J,MORENO-OTERO R.Pathophysiological basis for antioxidant therapy in chronic liver disease[J].Drugs,2005,65:2445-2461. 被引量：1
8LIEBER CS,LEO MA,CAO Q,et al.Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons[J].J Clin Gastroenterol,2003,37:336-339. 被引量：1
9MURRAY KF,CARITHERS RL.AASLD practice guidelines:Evaluation of the patient for liver transplantation[J].Hepatology,2005,41:1407-1432. 被引量：1
10LOK AS,MCMAHON BJ.Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations[J].Hepatology,2004,39:857-861. 被引量：1
7Tomer Y. Hepatitis C and interferon induced thyroiditis. Autoimmunity, 2010,34(3 ):322-326. 被引量：1
8Buskila D. Hepatitis C associated rheumatic disorders. Rheum Dis C lin North Am, 2009,35 ( 1 ):I 11-123. 被引量：1
9Tran HA, Reeves GE,Jones TL. The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection. QJM, 2009,102(2):117-122. 被引量：1
10Moustafa AH,Ali EMM,Mohamed TM,et al. Oxidative stress and thyroid hormones in patients with liver diseases. Eur J intern Mea, 2009,20(7):703-708. 被引量：1
